109 related articles for article (PubMed ID: 16531809)
1. The value of risk assessment and burden of disease analyses.
Lawes CM; Vander Hoorn S; Rodgers A
J Hypertens; 2006 Apr; 24(4):783-4. PubMed ID: 16531809
[No Abstract] [Full Text] [Related]
2. High blood pressure in Latin America: a call to action.
Rubinstein A; Alcocer L; Chagas A
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117
[TBL] [Abstract][Full Text] [Related]
3. Hypertension within the cardiovascular disease risk paradigm.
Alexander LM
JAAPA; 2007 Nov; Suppl Hypertension():3-8. PubMed ID: 18050529
[TBL] [Abstract][Full Text] [Related]
4. Nutrition and cardiovascular disease.
Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2499-506. PubMed ID: 17954523
[TBL] [Abstract][Full Text] [Related]
5. Clinical inquiries. Does treating diastolic BP to less than 90 mm Hg lower cardiovascular risk?
Fontaine P; Nashelsky J; Ward R
J Fam Pract; 2004 Feb; 53(2):144-6. PubMed ID: 14764300
[No Abstract] [Full Text] [Related]
6. Hypertension epidemiology and economic burden: refining risk assessment to lower costs.
Cohen JD
Manag Care; 2009 Oct; 18(10):51-8. PubMed ID: 19902690
[TBL] [Abstract][Full Text] [Related]
7. Global cardiovascular health promotion and disease prevention: 2011 and beyond.
Labarthe DR; Dunbar SB
Circulation; 2012 May; 125(21):2667-76. PubMed ID: 22644371
[No Abstract] [Full Text] [Related]
8. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
9. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
Gaziano TA
Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
[TBL] [Abstract][Full Text] [Related]
10. Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases.
Chockalingam A; Chalmers J; Whitworth J; Erdine S; Mancia G; Mendis S; Heagerty A
J Hypertens; 2008 Dec; 26(12):2255-8. PubMed ID: 19008700
[No Abstract] [Full Text] [Related]
11. The economic burden of chronic cardiovascular disease for major insurers.
Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and the UN Millennium Development Goals: time to move forward.
Fuster V; Vedanthan R
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):593. PubMed ID: 18813335
[No Abstract] [Full Text] [Related]
13. Cardioprotection: what is it? Who needs it?
Kannel WB
Am J Manag Care; 2002 Jun; 8(9 Suppl):5-12. PubMed ID: 12099329
[No Abstract] [Full Text] [Related]
14. Help lower the mercury and control high blood pressure.
Classé JG; Marshall EC
J Am Optom Assoc; 1996 May; 67(5):245-7. PubMed ID: 8888835
[No Abstract] [Full Text] [Related]
15. Cardiovascular disease in Mississippi.
Jones ES; Carr AD
J Miss State Med Assoc; 1995 Sep; 36(9):265-9. PubMed ID: 7473699
[No Abstract] [Full Text] [Related]
16. Risk prediction in subjects with high-normal blood pressure.
Schneider MP; Schmieder RE
J Hypertens; 2009 Jun; 27(6):1126-8. PubMed ID: 19454903
[No Abstract] [Full Text] [Related]
17. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease 2005--the global picture.
Callow AD
Vascul Pharmacol; 2006 Nov; 45(5):302-7. PubMed ID: 17074537
[TBL] [Abstract][Full Text] [Related]
19. [The contribution of risk factors to the burden of disease in Sweden. A comparison between Swedish and WHO data].
Agardh E; Moradi T; Allebeck P
Lakartidningen; 2008 Mar 12-18; 105(11):816-21. PubMed ID: 18461873
[No Abstract] [Full Text] [Related]
20. Physical fitness and physical activity at age 13 years as predictors of cardiovascular disease risk factors at ages 15, 25, 33, and 40 years: extended follow-up of the Oslo Youth Study.
Kvaavik E; Klepp KI; Tell GS; Meyer HE; Batty GD
Pediatrics; 2009 Jan; 123(1):e80-6. PubMed ID: 19117851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
